Radiosensitizers and protectors.
D004999:Amifostine / Q000627:therapeutic use; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D008920:Misonidazole / Q000627:therapeutic use; D009369:Neoplasms / Q000532:radiotherapy; D010100:Oxygen; D011743:Pyrimidines / Q000627:therapeutic use; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*
D011743:Pyrimidines; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D008795:Metronidazole; D008920:Misonidazole; D004999:Amifostine; D010100:Oxygen